BresaGen

BresaGen is based in Adelaide, South Australiaand operates a cGMP facility with the capacity to manufacture recombinant proteins and peptides. The Company has human therapeutic API candidates and offers contract process development and manufacturing services.

BresaGen has commercialised its first product, EquiGen™, a horse growth hormone, and executed its first contract for supply of human growth hormone API.

In the last 12 months the Company's protEcol™ Services has signed several contracts for process development and supply of material for pre-clinical and clinical studies.

Contact Details: PO Box 259 Rundle Mall South Australia 5000 Australia Tel: (+61) 8 8234 2660 Fax: (+61) 8 8234 6268 Email: adelaide@bresagen.com.au WWW: www.bresagen.com.au/

Recent Publications by BresaGen:
Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. The number of human embryonic stem cell (hESC) lines available to...	20th May, 2005	BresaGen, Inc., Athens, GA 30605, USA.	Stem Cells Dev. 2004 Dec;13(6):585-97. DOI Direct Link
Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. The use of human embryonic stem cells (hESCs) as a source of dopaminergic...	13th May, 2005	BresaGen Inc., 111 Riverbend Rd., Athens, Georgia, 30605, USA.	Stem Cells. 2004;22(7):1218-38. DOI Direct Link
An efficient method for producing alpha(1,3)-galactosyltransferase gene knockout pigs. We have reported relatively efficient methods for somatic cell nuclear...	23rd April, 2005	BresaGen Limited, Adelaide, South Australia, Australia.	Cloning Stem Cells. 2004;6(4):327-31. DOI Direct Link
Relationship between donor animal age, follicular fluid steroid content and oocyte developmental competence in the pig. The developmental competence of oocytes recovered from the ovaries of...	15th March, 2005	BresaGen Limited, Reproductive Biotechnology Division, Adelaide, SA 5000,	Reprod Fertil Dev. 2003;15(1-2):81-7.
Sex differentiation and germ cell production in chimeric pigs produced by inner cell mass injection into blastocysts. This study aimed at collecting background knowledge for chimeric pig...	16th December, 2004	Reproductive Biology Division, BresaGen Limited, Rundle Mall, Adelaide,	Biol Reprod. 2004 Mar;70(3):702-7. Epub 2003 Nov 12. DOI Direct Link
→View more BresaGen research publications.

BresaGen Patents:
US Patent No.	Title
7445931	Compositions and methods for enrichment of neural stem cells using ceramide analogs
7201899	Materials and methods for management of hyperacute rejection in human xenotransplantation
6849448	Pigs and pig cells having an inactivated .alpha. 1,3-galactosyl transferase gene
6749833	Design and planning system for improving the survival rate of injected structures
6465616	Interleukin-5 antagonist
→View more BresaGen patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1127 times since April 2007, the link to the organisation's website has been followed 280 times

Recent Search Terms used to find this page: bresagen australia | BresaGen | BRESAGEN AU | BresaGen | equigen bresagen | bresagen | bresagen | BresaGen | Bresagen Australia | BRESAGEN EQUIGEN | .

Search for more companies in Rundle Mall

Search for more companies in South Australia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BresaGen